Chemotherapy and Radioligand Therapy for Advanced Prostate Cancer

Lutetium 177: Targeted Treatment for Advanced Prostate Cancer ExplainedПодробнее

Real-World Evidence Influencing Academic-Setting Decisions About Radioligand Treatment TimingПодробнее

The Ongoing Journey Towards a Cancer CureПодробнее

Professor Michael Hofman talks new treatment for advanced prostate cancer.Подробнее

Harnessing Radioligand Therapy: Innovative Solutions for Advanced Prostate CancerПодробнее

Advanced #ProstateCancer Q&A | Eugene Kwon, MD & Mark Moyad, MD MPH | #PCRIПодробнее

Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRIПодробнее

ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice ShawПодробнее

Treatment Updates for Advanced Prostate Cancer – 2023 ZERO Prostate Cancer SummitПодробнее

Lu-PSMA Radioligand TherapyПодробнее

Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced ImagingПодробнее

Treatment for Advanced Prostate Cancer Patients | Lutetium 177 PSMA Radioligand Therapy | MercyПодробнее

Winship Grand Rounds: August 4, 2021 - Jonathan Strosberg, MDПодробнее

PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient ConferenceПодробнее

Dr. Oliver Sartor talks about a new treatment for advanced prostate cancerПодробнее

ARROW: PSMA-targeted radioligand therapy plus enzalutamide in mCRPCПодробнее

Lecture on medical oncology - highlights on medical treatment of advanced PCaПодробнее

Personalized Cancer Therapy: Using PSMA Radioligand Therapy of Metastatic Prostate CancerПодробнее

Updates in the management of neuroendocrine cancersПодробнее